The in vivo effects of the Pro12Ala PPARgamma2 polymorphism on adipose tissue NEFA metabolism: the first use of the Oxford Biobank.
AIMS/HYPOTHESIS: To investigate the phenotypic effects of common polymorphisms on adipose tissue metabolism and cardiovascular risk factors, we set out to establish a biobank with the unique feature of allowing a prospective recruit-by-genotype approach. The first use of this biobank investigates th...
| Main Authors: | , , , , , , , |
|---|---|
| Format: | Journal article |
| Language: | English |
| Published: |
2006
|
| _version_ | 1826300127651823616 |
|---|---|
| author | Tan, G Neville, M Liverani, E Humphreys, S Currie, J Dennis, L Fielding, B Karpe, F |
| author_facet | Tan, G Neville, M Liverani, E Humphreys, S Currie, J Dennis, L Fielding, B Karpe, F |
| author_sort | Tan, G |
| collection | OXFORD |
| description | AIMS/HYPOTHESIS: To investigate the phenotypic effects of common polymorphisms on adipose tissue metabolism and cardiovascular risk factors, we set out to establish a biobank with the unique feature of allowing a prospective recruit-by-genotype approach. The first use of this biobank investigates the effects of the peroxisome proliferator-activated receptor (PPAR) Pro12Ala polymorphism on integrative tissue-specific physiology. We hypothesised that Ala12 allele carriers demonstrate greater adipose tissue metabolic flexibility and insulin sensitivity. MATERIALS AND METHODS: From a comprehensive population register, subjects were recruited into a biobank, which was genotyped for the Pro12Ala polymorphism. Twelve healthy male Ala12 carriers and 12 matched Pro12 homozygotes underwent detailed physiological phenotyping using stable isotope techniques, and measurements of blood flow and arteriovenous differences in adipose tissue and muscle in response to a mixed meal containing [1,1,1-(13)C]tripalmitin. RESULTS: Of 6,148 invited subjects, 1,072 were suitable for inclusion in the biobank. Among Pro12 homozygotes, insulin sensitivity correlated with HDL-cholesterol concentrations, and inversely correlated with blood pressure, apolipoprotein B, triglyceride and total cholesterol concentrations. Ala12 carriers showed no such correlations. In the meal study, Ala12 carriers had lower plasma NEFA concentrations, higher adipose tissue and muscle blood flow, and greater insulin-mediated postprandial hormone-sensitive lipase suppression along with greater insulin sensitivity than Pro12 homozygotes. CONCLUSIONS/INTERPRETATION: This study shows that a recruit-by-genotype approach is feasible and describes the biobank's first application, providing tissue-specific physiological findings consistent with the epidemiological observation that the PPAR Ala12 allele protects against the development of type 2 diabetes. |
| first_indexed | 2024-03-07T05:12:26Z |
| format | Journal article |
| id | oxford-uuid:dc04bf4f-a37d-4851-8387-02a280338c0b |
| institution | University of Oxford |
| language | English |
| last_indexed | 2024-03-07T05:12:26Z |
| publishDate | 2006 |
| record_format | dspace |
| spelling | oxford-uuid:dc04bf4f-a37d-4851-8387-02a280338c0b2022-03-27T09:14:44ZThe in vivo effects of the Pro12Ala PPARgamma2 polymorphism on adipose tissue NEFA metabolism: the first use of the Oxford Biobank.Journal articlehttp://purl.org/coar/resource_type/c_dcae04bcuuid:dc04bf4f-a37d-4851-8387-02a280338c0bEnglishSymplectic Elements at Oxford2006Tan, GNeville, MLiverani, EHumphreys, SCurrie, JDennis, LFielding, BKarpe, FAIMS/HYPOTHESIS: To investigate the phenotypic effects of common polymorphisms on adipose tissue metabolism and cardiovascular risk factors, we set out to establish a biobank with the unique feature of allowing a prospective recruit-by-genotype approach. The first use of this biobank investigates the effects of the peroxisome proliferator-activated receptor (PPAR) Pro12Ala polymorphism on integrative tissue-specific physiology. We hypothesised that Ala12 allele carriers demonstrate greater adipose tissue metabolic flexibility and insulin sensitivity. MATERIALS AND METHODS: From a comprehensive population register, subjects were recruited into a biobank, which was genotyped for the Pro12Ala polymorphism. Twelve healthy male Ala12 carriers and 12 matched Pro12 homozygotes underwent detailed physiological phenotyping using stable isotope techniques, and measurements of blood flow and arteriovenous differences in adipose tissue and muscle in response to a mixed meal containing [1,1,1-(13)C]tripalmitin. RESULTS: Of 6,148 invited subjects, 1,072 were suitable for inclusion in the biobank. Among Pro12 homozygotes, insulin sensitivity correlated with HDL-cholesterol concentrations, and inversely correlated with blood pressure, apolipoprotein B, triglyceride and total cholesterol concentrations. Ala12 carriers showed no such correlations. In the meal study, Ala12 carriers had lower plasma NEFA concentrations, higher adipose tissue and muscle blood flow, and greater insulin-mediated postprandial hormone-sensitive lipase suppression along with greater insulin sensitivity than Pro12 homozygotes. CONCLUSIONS/INTERPRETATION: This study shows that a recruit-by-genotype approach is feasible and describes the biobank's first application, providing tissue-specific physiological findings consistent with the epidemiological observation that the PPAR Ala12 allele protects against the development of type 2 diabetes. |
| spellingShingle | Tan, G Neville, M Liverani, E Humphreys, S Currie, J Dennis, L Fielding, B Karpe, F The in vivo effects of the Pro12Ala PPARgamma2 polymorphism on adipose tissue NEFA metabolism: the first use of the Oxford Biobank. |
| title | The in vivo effects of the Pro12Ala PPARgamma2 polymorphism on adipose tissue NEFA metabolism: the first use of the Oxford Biobank. |
| title_full | The in vivo effects of the Pro12Ala PPARgamma2 polymorphism on adipose tissue NEFA metabolism: the first use of the Oxford Biobank. |
| title_fullStr | The in vivo effects of the Pro12Ala PPARgamma2 polymorphism on adipose tissue NEFA metabolism: the first use of the Oxford Biobank. |
| title_full_unstemmed | The in vivo effects of the Pro12Ala PPARgamma2 polymorphism on adipose tissue NEFA metabolism: the first use of the Oxford Biobank. |
| title_short | The in vivo effects of the Pro12Ala PPARgamma2 polymorphism on adipose tissue NEFA metabolism: the first use of the Oxford Biobank. |
| title_sort | in vivo effects of the pro12ala ppargamma2 polymorphism on adipose tissue nefa metabolism the first use of the oxford biobank |
| work_keys_str_mv | AT tang theinvivoeffectsofthepro12alappargamma2polymorphismonadiposetissuenefametabolismthefirstuseoftheoxfordbiobank AT nevillem theinvivoeffectsofthepro12alappargamma2polymorphismonadiposetissuenefametabolismthefirstuseoftheoxfordbiobank AT liveranie theinvivoeffectsofthepro12alappargamma2polymorphismonadiposetissuenefametabolismthefirstuseoftheoxfordbiobank AT humphreyss theinvivoeffectsofthepro12alappargamma2polymorphismonadiposetissuenefametabolismthefirstuseoftheoxfordbiobank AT curriej theinvivoeffectsofthepro12alappargamma2polymorphismonadiposetissuenefametabolismthefirstuseoftheoxfordbiobank AT dennisl theinvivoeffectsofthepro12alappargamma2polymorphismonadiposetissuenefametabolismthefirstuseoftheoxfordbiobank AT fieldingb theinvivoeffectsofthepro12alappargamma2polymorphismonadiposetissuenefametabolismthefirstuseoftheoxfordbiobank AT karpef theinvivoeffectsofthepro12alappargamma2polymorphismonadiposetissuenefametabolismthefirstuseoftheoxfordbiobank AT tang invivoeffectsofthepro12alappargamma2polymorphismonadiposetissuenefametabolismthefirstuseoftheoxfordbiobank AT nevillem invivoeffectsofthepro12alappargamma2polymorphismonadiposetissuenefametabolismthefirstuseoftheoxfordbiobank AT liveranie invivoeffectsofthepro12alappargamma2polymorphismonadiposetissuenefametabolismthefirstuseoftheoxfordbiobank AT humphreyss invivoeffectsofthepro12alappargamma2polymorphismonadiposetissuenefametabolismthefirstuseoftheoxfordbiobank AT curriej invivoeffectsofthepro12alappargamma2polymorphismonadiposetissuenefametabolismthefirstuseoftheoxfordbiobank AT dennisl invivoeffectsofthepro12alappargamma2polymorphismonadiposetissuenefametabolismthefirstuseoftheoxfordbiobank AT fieldingb invivoeffectsofthepro12alappargamma2polymorphismonadiposetissuenefametabolismthefirstuseoftheoxfordbiobank AT karpef invivoeffectsofthepro12alappargamma2polymorphismonadiposetissuenefametabolismthefirstuseoftheoxfordbiobank |